NASDAQ:CRON Cronos Group (CRON) Stock Price, News & Analysis $2.42 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$2.40▼$2.4550-Day Range$2.23▼$2.7952-Week Range$1.64▼$3.14Volume401,686 shsAverage Volume2.43 million shsMarket Capitalization$925.12 millionP/E RatioN/ADividend YieldN/APrice Target$3.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Cronos Group alerts: Email Address Cronos Group MarketRank™ Stock AnalysisAnalyst RatingSell1.00 Rating ScoreUpside/Downside24.0% Upside$3.00 Price TargetShort InterestHealthy2.70% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.60Based on 6 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.01) to $0.07 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.91 out of 5 starsMedical Sector838th out of 936 stocksMedicinals & Botanicals Industry10th out of 12 stocks 1.5 Analyst's Opinion Consensus RatingCronos Group has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageCronos Group has only been the subject of 1 research reports in the past 90 days.Read more about Cronos Group's stock forecast and price target. Previous Next 4.0 Short Interest Percentage of Shares Shorted2.70% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cronos Group has recently decreased by 4.08%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRON. Previous Next 3.1 News and Social Media Coverage News SentimentCronos Group has a news sentiment score of 0.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Cronos Group this week, compared to 3 articles on an average week.Search Interest11 people have searched for CRON on MarketBeat in the last 30 days. This is an increase of 267% compared to the previous 30 days.MarketBeat Follows6 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 6.90% of the stock of Cronos Group is held by insiders.Percentage Held by InstitutionsOnly 8.71% of the stock of Cronos Group is held by institutions.Read more about Cronos Group's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Cronos Group are expected to grow in the coming year, from ($0.01) to $0.07 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is -16.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is -16.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cronos Group's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…Check out the new "Crypto Bull Run Millionaire Blueprint" now! About Cronos Group Stock (NASDAQ:CRON)Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.Read More CRON Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRON Stock News HeadlinesJuly 25 at 4:15 PM | globenewswire.comCronos Group Inc. to Hold 2024 Second Quarter Earnings Conference Call on August 8, 2024July 24 at 6:01 PM | benzinga.comLatest Cannabis Hires And Board Changes, Here's What You Need To KnowJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 22, 2024 | benzinga.comCannabis Stocks React To Biden Announcement: Monday's Closing Market MovesJuly 22, 2024 | globenewswire.comCronos Group Inc. Announces Results of Reconvened 2024 Annual Meeting of ShareholdersJuly 19, 2024 | finance.yahoo.comIndividual investors own 40% of Cronos Group Inc. (TSE:CRON) shares but public companies control 41% of the companyJuly 14, 2024 | investorplace.com3 Growth Stocks to Buy Before They Surge on EBITDA BreakevenJuly 13, 2024 | investorplace.com3 Cannabis Stocks That Will Thrive With or Without ReformsJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 11, 2024 | investorplace.com3 Budget-Friendly Stocks With Millionaire-Making PotentialJuly 9, 2024 | investorplace.com7 Pot Stock Pioneers Poised for High ReturnsJuly 9, 2024 | investorplace.com3 Cannabis Stocks Ready to Blaze as Regulations EaseJuly 6, 2024 | investorplace.com3 Meme Stocks That Could Make Your Grandchildren RichJuly 5, 2024 | globenewswire.comCronos Group Inc. to Reconvene Virtual 2024 Annual Meeting of ShareholdersJuly 5, 2024 | investorplace.comBudding Fortunes: 7 Cannabis Stocks With the Potential to Make You a MillionaireJuly 3, 2024 | investorplace.comThe 3 Best Cannabis Stocks to Buy in July 2024June 27, 2024 | investorplace.com7 Growth Stocks That Will Outperform the Markets Through 2028June 27, 2024 | globenewswire.comCronos Brand Spinach® Celebrates Summer with New LaunchesSee More Headlines Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today7/26/2024Next Earnings (Confirmed)8/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medicinals & botanicals Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:CRON CUSIPN/A CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees450Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.50 Low Stock Price Target$2.50 Potential Upside/Downside+24.0%Consensus RatingSell Rating Score (0-4)1.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.15) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-73,960,000.00 Net Margins-61.31% Pretax Margin-61.53% Return on Equity-3.06% Return on Assets-2.97% Debt Debt-to-Equity RatioN/A Current Ratio28.19 Quick Ratio27.28 Sales & Book Value Annual Sales$87.24 million Price / Sales10.60 Cash FlowN/A Price / Cash FlowN/A Book Value$2.87 per share Price / Book0.84Miscellaneous Outstanding Shares382,280,000Free Float355,904,000Market Cap$925.12 million OptionableOptionable Beta1.00 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. James Andrew McGinness III (Age 45)VP, Controller & Principal Accounting Officer Mr. Shayne J. LaidlawDirector of Investor Relations & StrategyMr. Adam Wagner (Age 41)Senior VP & Head of Cronos Israel Key CompetitorsArcellxNASDAQ:ACLXXenon PharmaceuticalsNASDAQ:XENEMerusNASDAQ:MRUSADMA BiologicsNASDAQ:ADMARhythm PharmaceuticalsNASDAQ:RYTMView All CompetitorsInstitutional OwnershipSeaCrest Wealth Management LLCBought 40,220 shares on 7/22/2024Ownership: 0.028%Baader Bank AktiengesellschaftBought 120,791 shares on 7/17/2024Ownership: 0.052%Virtu Financial LLCBought 27,446 shares on 5/20/2024Ownership: 0.028%Tidal Investments LLCBought 6,596,457 shares on 5/17/2024Ownership: 1.727%Walleye Trading LLCBought 194,000 shares on 5/17/2024Ownership: 0.000%View All Institutional Transactions CRON Stock Analysis - Frequently Asked Questions How have CRON shares performed this year? Cronos Group's stock was trading at $2.09 at the beginning of the year. Since then, CRON stock has increased by 15.8% and is now trading at $2.42. View the best growth stocks for 2024 here. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) posted its earnings results on Thursday, May, 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.01). The firm earned $25.29 million during the quarter, compared to analysts' expectations of $24.30 million. Cronos Group had a negative net margin of 61.31% and a negative trailing twelve-month return on equity of 3.06%. Who are Cronos Group's major shareholders? Cronos Group's top institutional investors include Baader Bank Aktiengesellschaft (0.05%) and SeaCrest Wealth Management LLC (0.03%). View institutional ownership trends. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cronos Group investors own include Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD) and Dollar Tree (DLTR). This page (NASDAQ:CRON) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
